904815-05-0 Usage
Uses
Used in Pharmaceutical and Agrochemical Industries:
4-Fluoro-1,2-benzisoxazol-3-amine is used as a key intermediate in the synthesis of pharmaceuticals and agrochemicals. Its unique structure and properties make it a valuable building block for the development of new drugs and pesticides.
Used in Medicinal Chemistry Research:
4-Fluoro-1,2-benzisoxazol-3-amine has potential applications in the field of medicinal chemistry, where it can be used to explore the synthesis of biologically active molecules and potentially valuable compounds for various therapeutic applications.
Used in Chemical Industry for Research and Development:
4-Fluoro-1,2-benzisoxazol-3-amine is important for research and development in the chemical industry. Its properties and structure make it a useful intermediate for the synthesis of a wide range of organic compounds, contributing to the advancement of chemical science and technology.
Check Digit Verification of cas no
The CAS Registry Mumber 904815-05-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,4,8,1 and 5 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 904815-05:
(8*9)+(7*0)+(6*4)+(5*8)+(4*1)+(3*5)+(2*0)+(1*5)=160
160 % 10 = 0
So 904815-05-0 is a valid CAS Registry Number.
904815-05-0Relevant articles and documents
Application of a recyclable fluorous oxime in the convenient synthesis of 3-amino-1,2-benzisoxazoles and 4-amino-1H-2,3-benzoxazines
Ang, Wei Jie,Chu, Chi-Yuan,Chou, Tzyy-Chao,Lo, Lee-Chiang,Lam, Yulin
, p. 780 - 785 (2013/04/10)
A microwave-assisted, fluorous synthetic route to 3-amino-1,2- benzisoxazoles and 4-amino-1H-2,3-benzoxazines has been developed. The strategy comprises linking the respective 2-fluorobenzonitrile or 2-(bromomethyl) benzonitrile to a fluorous oxime tag to give an aryloxime intermediate which then undergoes cyclization with concomitant cleavage of the substrate-tag in acidic conditions to provide the desired product in good to moderate yields. In addition, the aryloxime intermediate could be subjected to further reactions to expand the compound library. The product could be easily separated using fluorous solid-phase extraction (F-SPE) and the fluorous ketone recovered could be converted back to the fluorous oxime and reused in the next run of the synthesis.
